Litcius/Paper detail

LncRNA <i>MAGI2-AS3</i> Upregulates Cytokine Signaling 1 by Sponging <i>miR-155</i> in Non-Small Cell Lung Cancer

Feng Li, Qing Hu, Zhonghao Pang, Xiuquan Xu

2020Cancer Biotherapy and Radiopharmaceuticals22 citationsDOI

Abstract

Background: MAGI2-AS3 has been reported to be a tumor suppressor in breast cancer and bladder cancer. This study analyzed the role of MAGI2-AS3 in non-small cell lung cancer (NSCLC). Results: The authors found that MAGI2-AS3 and suppressor of cytokine signaling 1 ( SOCS-1 ) were both downregulated in NSCLC. MAGI2-AS3 and SOCS-1 were significantly and positively correlated in NSCLC tumor tissues. During follow-up, low levels of MAGI2-AS3 and SOCS-1 were found to be significantly correlated with patients' poor survival. In NSCLC cells, MAGI2-AS3 overexpression mediated the upregulated, while miR-155 expression mediated the downregulated SOCS-1 overexpression. RNA binding analysis showed that MAGI2-AS3 may be a sponge of miR-155 . Cell proliferation revealed decreased cell proliferation rate of NSCLC cells after MAGI2-AS3 and SOCS-1 overexpression. MiR-155 played an opposite role and reduced the effects of MAGI2-AS3 overexpression. Conclusion: Therefore, MAGI2-AS3 upregulates cytokine signaling 1 by sponging miR-155 to inhibit NSCLC cell proliferation.

Topics & Concepts

Cancer researchCytokineCell growthMedicineLung cancerCellCancerDownregulation and upregulationInternal medicineBiologyGeneGeneticsBiochemistryCancer-related molecular mechanisms researchRNA modifications and cancerCytokine Signaling Pathways and Interactions
LncRNA <i>MAGI2-AS3</i> Upregulates Cytokine Signaling 1 by Sponging <i>miR-155</i> in Non-Small Cell Lung Cancer | Litcius